Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azarga Add-on in Glaucoma or Ocular Hypertension Uncontrolled on Prostaglandins
NCT01263444Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of brinzolamide in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Alcon Inc.. Started Mar 2011; status: completed.
02
Drugs
brinzolamide
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01263444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01263444.